ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 31282895

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis.

Gentile MT and 3 others. J Vis Exp, 2019. Cited by 32 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis. Papers, record 31282895. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31282895

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis.
PubMed
Journal
J Vis Exp
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Video-Audio Media
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.51
iCite
Revised in PubMed
2020-06-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gentile MTMaria Teresa
2Pastorino OOlga
3Bifulco MMaurizio
4Colucci-D'Amato LLuca

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological AssayMajor topic
Biological ProductsMajor topic
Human Umbilical Vein Endothelial CellsMajor topic
Neovascularization, PhysiologicMajor topic
Cell Differentiation
Cell Movement
Cell Proliferation
Humans
MAP Kinase Signaling System
Mitogen-Activated Protein Kinase Kinases
Ruta
Rutin

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
41,125,751Erdafitinib suppresses pathological retinal angiogenesis via dual targeting of FGFR and VEGFR2 signaling.Sci Rep2025https://conductscience.org/library/papers/41125751PubMed
40,736,523The Anti-Angiogenic Effect of Microbotox on Rosacea Is Due to the Suppressed Secretion of VEGF by Mast Cells Resulting From Internalization of the MRGPRX2 Receptor.Ann Dermatol2025https://conductscience.org/library/papers/40736523PubMed
40,539,464Recombinant chromosome 6 open reading frame 120 protein promotes angiogenesis and endothelial‑to‑mesenchymal transition in human umbilical vein endothelial cells via the PI3K/Akt signaling pathway.Mol Med Rep2025https://conductscience.org/library/papers/40539464PubMed
40,195,2831,3,5-Tricaffeoylquinic Acid from Ipomoea batatas Vines Induced Ovarian Cancer Cell Apoptosis and Inhibited Endothelial Tube Formation.Biomol Ther (Seoul)2025https://conductscience.org/library/papers/40195283PubMed
39,415,271ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway.Biol Direct2024https://conductscience.org/library/papers/39415271PubMed
39,113,612Ghrelin induced by ultraviolet B exposure promotes the restoration of diabetic cutaneous wound healing.Skin Res Technol2024https://conductscience.org/library/papers/39113612PubMed
38,944,663The effects of Quercetin on wound healing in the human umbilical vein endothelial cells.Cell Tissue Bank2024https://conductscience.org/library/papers/38944663PubMed
38,627,796
Increased levels of villus-derived exosomal miR-29a-3p in normal pregnancy than uRPL patients suppresses decidual NK cell production of interferon-γ and exerts a therapeutic effect in abortion-prone mice.
Cell Commun Signal2024https://conductscience.org/library/papers/38627796PubMed
37,835,469αV-Integrin-Dependent Inhibition of Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry by the uPAcyclin Decapeptide.Cancers (Basel)2023https://conductscience.org/library/papers/37835469PubMed
37,593,607Brevilin A exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling invitro.Heliyon2023https://conductscience.org/library/papers/37593607PubMed

1 to 10 of 21

See all 21 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MAP2K75,609PubTator's text mininghttps://conductscience.org/library/genes/5609

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31282895

GET https://conductscience.org/api/papers/v1/31282895/cited_by?page=2

API referenceFor AI assistants